TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells

Molecular Immunology

Volumn 45, Issue 1, 2008, Pages 244-252

  Theiner, Gabi ^a   Rößner, Susanne ^a   Dalpke, Alexander ^c   Bode, Konrad ^c   Berger, Thomas ^a   Gessner, André ^b   Lutz, Manfred B ^a,d  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Dendritic cells; Interleukins; Toll like receptors

Indexed keywords

CD40 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; IMIQUIMOD; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; OUTER SURFACE PROTEIN A; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL MATURATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, CD40; BONE MARROW CELLS; CROSS-LINKING REAGENTS; DENDRITIC CELLS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOSOMES; OLIGODEOXYRIBONUCLEOTIDES; SIGNAL TRANSDUCTION; TIME FACTORS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

MURINAE;

EID: 34548209246     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.02.021     Document Type: Article

References (54)

1. Abdi K., Singh N., and Matzinger P. T-cell control of IL-12p75 production. Scand. J. Immunol. 64 (2006) 83-92
2. Ahmad-Nejad P., Hacker H., Rutz M., Bauer S., Vabulas R.M., and Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32 (2002) 1958-1968
3. Albrecht I., Tapmeier T., Zimmermann S., Frey M., Heeg K., and Dalpke A. Toll-like receptors differentially induce nucleosome remodelling at the IL-12p40 promoter. EMBO Rep. 5 (2004) 172-177
4. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 (2001) 732-738
5. Barton G.M., and Medzhitov R. Toll-like receptor signaling pathways. Science 300 (2003) 1524-1525
6. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., and Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184 (1996) 747-752
7. Crabtree T.D., Jin L., Raymond D.P., Pelletier S.J., Houlgrave C.W., Gleason T.G., Pruett T.L., and Sawyer R.G. Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge. Infect. Immun. 69 (2001) 2123-2129
8. Dalpke A.H., Zimmermann S., Albrecht I., and Heeg K. Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo. Immunology 106 (2002) 102-112
9. Diebold S.S., Kaisho T., Hemmi H., Akira S., and Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004) 1529-1531
10. Farman C.A., and Kornbrust D.J. Oligodeoxynucleotide studies in primates: antisense and immune stimulatory indications. Toxicol. Pathol. 31 Suppl. (2003) 119-122
11. Fujimoto C., Nakagawa Y., Ohara K., and Takahashi H. Polyriboinosinic polyribocytidylic acid [Poly(I:C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8+ cytotoxic T lymphocytes. Int. Immunol. 16 (2004) 55-63
12. Gao J.J., Xue Q., Papasian C.J., and Morrison D.C. Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-alpha through a post-transcriptional mechanism. J. Immunol. 166 (2001) 6855-6860
13. Gautier G., Humbert M., Deauvieau F., Scuiller M., Hiscott J., Bates E.E., Trinchieri G., Caux C., and Garrone P. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 201 (2005) 1435-1446
14. Hajjar A.M., O'Mahony D.S., Ozinsky A., Underhill D.M., Aderem A., Klebanoff S.J., and Wilson C.B. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol. 166 (2001) 15-19
15. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., and Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
16. Himmelrich H., Launois P., Maillard I., Biedermann T., Tacchini-Cottier F., Locksley R.M., Rocken M., and Louis J.A. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J. Immunol. 164 (2000) 4819-4825
17. Kaisho T., and Akira S. Dendritic cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol. 22 (2001) 78-83
18. Kaisho T., Takeuchi O., Kawai T., Hoshino K., and Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 166 (2001) 5688-5694
19. Kalinski P., Schuitemaker J.H., Hilkens C.M., Wierenga E.A., and Kapsenberg M.L. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J. Immunol. 162 (1999) 3231-3236
20. Kawai T., Adachi O., Ogawa T., Takeda K., and Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11 (1999) 115-122
21. Koch F., Stanzl U., Jennewein P., Janke K., Heufler C., Kampgen E., Romani N., and Schuler G. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184 (1996) 741-746
22. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20 (2002) 709-760
23. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., and Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223 (1999) 77-92
24. Mazzoni A., and Segal D.M. Controlling the Toll road to dendritic cell polarization. J. Leukoc. Biol. 75 (2004) 721-730
25. Medzhitov R., and Janeway Jr. C. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173 (2000) 89-97
26. Medzhitov R., and Janeway Jr. C. The Toll receptor family and microbial recognition. Trends Microbiol. 8 (2000) 452-456
27. Menges M., Rossner S., Voigtlander C., Schindler H., Kukutsch N.A., Bogdan C., Erb K., Schuler G., and Lutz M.B. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195 (2002) 15-21
28. Napolitani G., Rinaldi A., Bertoni F., Sallusto F., and Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6 (2005) 769-776
29. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., Nakanishi K., Kimoto M., Miyake K., Takeda K., and Akira S. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J. Immunol. 164 (2000) 3476-3479
30. O'Neill L.A. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal?. Trends Immunol. 23 (2002) 296-300
31. O'Neill L.A. The role of MyD88-like adapters in Toll-like receptor signal transduction. Biochem. Soc. Trans. 31 (2003) 643-647
32. O'Neill L.A., Fitzgerald K.A., and Bowie A.G. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24 (2003) 286-290
33. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
34. Qureshi S.T., Lariviere L., Leveque G., Clermont S., Moore K.J., Gros P., and Malo D. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189 (1999) 615-625
35. Rao A.S., Dvorchik I., Dodson F., Abu-Elmagd K., Schaefer A.T., Ostrowski L., Valenti M., Zeevi A., Kuddus R., Starzl T.E., and Fung J.J. Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection. Transplant Proc. 33 (2001) 1352
36. Re F., and Strominger J.L. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J. Immunol. 173 (2004) 7548-7555
37. Reis e Sousa C. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin. Immunol. 16 (2004) 27-34
38. Sands H., Gorey-Feret L.J., Ho S.P., Bao Y., Cocuzza A.J., Chidester D., and Hobbs F.W. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3′,5′-blocked oligonucleotides. Mol. Pharmacol. 47 (1995) 636-646
39. Sato S., Nomura F., Kawai T., Takeuchi O., Muhlradt P.F., Takeda K., and Akira S. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J. Immunol. 165 (2000) 7096-7101
40. Sparwasser T., Koch E.S., Vabulas R.M., Heeg K., Lipford G.B., Ellwart J.W., and Wagner H. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28 (1998) 2045-2054
41. Takeda K., and Akira S. Microbial recognition by Toll-like receptors. J. Dermatol. Sci. 34 (2004) 73-82
42. Takeda K., and Akira S. TLR signaling pathways. Semin. Immunol. 16 (2004) 3-9
43. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int. Immunol. 17 (2005) 1-14
44. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu. Rev. Immunol. 21 (2003) 335-376
45. Weighardt H., Jusek G., Mages J., Lang R., Hoebe K., Beutler B., and Holzmann B. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells. Eur. J. Immunol. 34 (2004) 558-564
46. Weinmann A.S., Mitchell D.M., Sanjabi S., Bradley M.N., Hoffmann A., Liou H.C., and Smale S.T. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nat. Immunol. 2 (2001) 51-57
47. Weinmann A.S., Plevy S.E., and Smale S.T. Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription. Immunity 11 (1999) 665-675
48. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., and Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 (2003) 640-643
49. Yeo S.J., Yoon J.G., Hong S.C., and Yi A.K. CpG DNA induces self and cross-hyporesponsiveness of RAW264.7 cells in response to CpG DNA and lipopolysaccharide: alterations in IL-1 receptor-associated kinase expression. J. Immunol. 70 (2003) 1052-1061
50. Yi A.K., Yoon J.G., Hong S.C., Redford T.W., and Krieg A.M. Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-alpha production through activation of NF-kappaB. Int. Immunol. 13 (2001) 1391-1404
51. Zal T., Volkmann A., and Stockinger B. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180 (1994) 2089-2099
52. Zhao Q., Matson S., Herrera C.J., Fisher E., Yu H., and Krieg A.M. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3 (1993) 53-66
53. Ziegler-Heitbrock H.W. Molecular mechanism in tolerance to lipopolysaccharide. J. Inflamm. 45 (1995) 13-26
54. Zimmermann S., Heeg K., and Dalpke A. Immunostimulatory DNA as adjuvant: efficacy of phosphodiester CpG oligonucleotides is enhanced by 3′ sequence modifications. Vaccine 21 (2003) 990-995